Vaccine uptake rate by vaccine dose and exact 95% confidence intervals were computed with R statistical software 2.12.1 (R Foundation for Statistical Computing, Vienna, Austria). Cumulative vaccine coverage curves by age (in days and converted into months) were also calculated. According to the recommendation of the Canadian Immunization Registry Network, 9,10 a delay in vaccine administration was defined as a dose given more than 4 weeks after the recommended age. The study protocol was approved by the Quebec University Hospital Research Ethics Committee and by the Directors of the two regional health centres of Nunavik (Inuulitsivik Health Centre, Puvirnituk, and Ungava Tulattavik Health Centre, Kuujjuaq).
RESULTS
A total of 3,505 children born in the period January 1, 1994 to December 31, 2005 and who had resided in Nunavik during the first five years of their life were identified. Of these, 280 children (8.0% of the total) were excluded because their medical file or immunization card was not found or was grossly incomplete, signaling an early death, an early departure or a transitory stay in the region. Thus, the statistical analysis included 3,223 children; 48.9% were female (1,576/3,211 whose sex was indicated). PCV7 dose is shown in Figure 1 . All of these children should have received at least one PCV7 dose and the overall ≥1 dose coverage was 84.3% (95% CI: 82.1%-86.2%). The recommended number of PCV7 doses varied according to the age of each child when seen at a vaccination clinic. Only 11.7% (95% CI: 10%-13.7%) had received four doses before their 5 th birthday anniversary. 
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Group III
DISCUSSION
The implementation of the pneumococcal conjugate vaccine program in December 2004 in the province of Quebec (16 out of 18 health regions) was highly successful in terms of coverage rates, both in infants targeted by the routine 3-dose program and older children targeted by the catch-up campaign. 11 Results of the 2012 Quebec provincial immunization survey showed that 93.1% of children are receiving the recommended 3 doses by age 2 years. 12 Results of the current study confirm that the performance was as good in the mostly Inuit population of Nunavik: more than 80% of children targeted by the catch-up campaign received at least one PCV7 dose, more than 90% of infants are routinely receiving the recommended four doses (because they are considered to be at high risk), and the majority of doses were administered in the desired age-window. Vaccine uptake rates in Nunavik were much higher than those observed (approximately 43%) in low-income communities of Saskatoon (SK) with a high proportion of Aboriginal children, 13 and comparable with those observed in Alaska. 14, 15 Although the overall performance of primary health care services in Nunavik is satisfactory, efforts should be made to better understand obstacles to immunization in the region, especially in villages with uptake lower than 90%.
Obtaining information on vaccine uptake in Aboriginal populations of Canada is particularly challenging. National immunization surveys have been periodically conducted since 1994, first by Health Canada and thereafter by the Public Health Agency of Canada. 16 In the 2004 survey, computer-assisted telephone interviews were performed with approximately 1,500 parents of children aged between 20 and 40 months, aged 7 years and aged 17 years, in seven regions: British Columbia, Alberta, Manitoba and Saskatchewan, Ontario, Quebec, the Atlantic Provinces, and the territories. 16 The most recent survey was conducted in 2011, in a sample of approximately 2,800 children aged 2, 7, 10 to 14 (girls) and 17 years, living in the 10 provinces and 3 territories, not residing in institutions or reserves. 17 Results have not been published yet. The sampling process, sample size and data collection methods of these national surveys are not suitable to provide precise and valid estimates of vaccination coverage in aboriginal populations. In the province of Quebec, the two northern regions of Nunavik and Terres-Cries-de-la-Baie-James are excluded from childhood immunization surveys conducted every two years. 12 Population-based centralized immunization registries are a solution to overcoming linguistic and cultural barriers to health surveys in high-risk population groups. Moreover, computerized records could facilitate the work of health professionals in assessing the immunization status of patients and calling those eligible for vaccine administration at a given age. In Quebec, the implementation of an integrated information system on immunization is planned but it will take years to be fully operational in the two Nordic regions. Investment will be needed for this, not so much in equipment, but in the training of personnel. In the meantime, time-consuming and expensive surveys involving travel and stays in each village are requested for collecting data at the individual level.
There are several limitations to our study. First, no reliable information could be collected for approximately 8% of children in the study population. Uptake rates in this group could be different than in the group included in statistical analyses. However, even a large difference would not affect overall estimates greatly. In small villages, estimates of vaccine coverage are not statistically precise and this is why confidence intervals and statistical tests were not performed at this level. Finally, a positive history of vaccination is confirmed by a written document while a negative history is always presumptive. Uptake rates measured in our study can thus be considered as the lowest possible values. 
CONCLUSIONS
